With regard to the DNA repair system, it has been shown that specific MERK/ERK and PI3K inhibitors prevent ERCC1 induction, whereas JNK and p38 inhibitors are without effects in human hepatoma cells [59]. The gene discussed is MAPK8; the disease is hepatocellular carcinoma.